pamidronate and 1,25-dihydroxyergocalciferol

pamidronate has been researched along with 1,25-dihydroxyergocalciferol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mautalen, C; Pérez Lloret, A; Roldán, EJ; Vega, E1
Brown, E; Butters, R; Egbuna, O; Goltzman, D; Kantham, L; Pang, J; Pollak, M; Quinn, S1

Trials

1 trial(s) available for pamidronate and 1,25-dihydroxyergocalciferol

ArticleYear
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
    Drugs under experimental and clinical research, 1994, Volume: 20, Issue:3

    Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalciferols; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tablets, Enteric-Coated

1994

Other Studies

1 other study(ies) available for pamidronate and 1,25-dihydroxyergocalciferol

ArticleYear
The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:3

    Topics: Animals; Calcitonin; Calcium; Calcium, Dietary; Creatinine; Diphosphonates; Duodenum; Ergocalciferols; Gene Expression Regulation; Genotype; Injections, Intraperitoneal; Intestinal Absorption; Kidney; Mice; Mice, Knockout; Pamidronate; Parathyroid Hormone; Phenotype; Receptors, Calcium-Sensing

2009